Hans Mies, PhD
Hans Mies is a Partner at KPMG, a multinational professional services network. Dr. Mies is responsible for implementing business models that meet the challenges caused by emerging developments in the areas of tax, regulatory, and broader industry trends in the life science and chemicals industries. Dr. Mies joined KPMG Netherlands in 2004, dedicating his time to pharmaceutical tax optimized supply chain and value chain conversions. After working at Nobel Biocare and Deloitte, Dr. Mies returned to KPMG Switzerland in 2015 to consult multinationals corporations in international matters such as growth strategies for clinical-stage biopharmaceutical companies, commercial strategy, and market entry and business model definition. Dr. Mies has assisted several biopharmaceutical companies in their definition of their expansion strategies into the European market. Dr. Mies received his LLM and PhD in International Tax Law at Tilburg University.